Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cutaneous Methotrexate-Related Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in a Patient with Granulomatous Cutaneous T-Cell Lymphoma: A Case Report and Literature Review.
Kositkuljorn C, Rutnin S, Rattananukrom T, Puavilai T, Khiankaew B, Boonsakan P, Iamsumang W. Kositkuljorn C, et al. Among authors: puavilai t. Clin Cosmet Investig Dermatol. 2023 Aug 15;16:2229-2235. doi: 10.2147/CCID.S419534. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 37601419 Free PMC article.
Cytotoxicity and exhaustion markers of chimeric antigen receptor T cells targeting BCMA in multiple myeloma cell lines between patients and healthy donors.
Prasongtanakij S, Preedagasamzin S, Jittorntrum B, Anurathapan U, Puavilai T, Niparuck P, Chantrathammachart P, Piyajaroenkij T, Uaesoontrachoon K, Uchibori R, Ozawa K, Ohmine K, Hongeng S. Prasongtanakij S, et al. Among authors: puavilai t. Eur J Haematol. 2024 Feb;112(2):248-256. doi: 10.1111/ejh.14007. Epub 2023 May 24. Eur J Haematol. 2024. PMID: 37222081
Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWG.
Kungwankiattichai S, Owattanapanich W, Rattanathammethee T, Rattarittamrong E, Chanswangphuwana C, Polprasert C, Limvorapitak W, Saengboon S, Niparuck P, Puavilai T, Julamanee J, Saelue P, Wanitpongpun C, Prayongratana K, Sriswasdi C, Nakhakes C. Kungwankiattichai S, et al. Among authors: puavilai t. Hematology. 2023 Dec;28(1):2191462. doi: 10.1080/16078454.2023.2191462. Hematology. 2023. PMID: 36951362
External validation and comparison of IPI, R-IPI, and NCCN-IPI in diffuse large B-cell lymphoma patients treated with R-CHOP to predict 2-year progression-free survival.
Warnnissorn N, Kanitsap N, Niparuck P, Boonsakan P, Kulalert P, Limvorapitak W, Bhoopat L, Saengboon S, Chantrathammachart P, Puavilai T, Chuncharunee S. Warnnissorn N, et al. Among authors: puavilai t. Hematology. 2022 Dec;27(1):1237-1245. doi: 10.1080/16078454.2022.2147916. Hematology. 2022. PMID: 36413354
Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group.
Chanswangphuwana C, Polprasert C, Owattanapanich W, Kungwankiattichai S, Tantiworawit A, Rattanathammethee T, Limvorapitak W, Saengboon S, Niparuck P, Puavilai T, Julamanee J, Saelue P, Wanitpongpun C, Nakhakes C, Prayongratana K, Sriswasdi C. Chanswangphuwana C, et al. Among authors: puavilai t. Clin Lymphoma Myeloma Leuk. 2022 Dec;22(12):e1075-e1083. doi: 10.1016/j.clml.2022.08.010. Epub 2022 Aug 23. Clin Lymphoma Myeloma Leuk. 2022. PMID: 36117042
Comparison of Three Doses of Cytarabine Consolidation for Intermediate- and Adverse-risk Acute Myeloid Leukemia: Real World Evidence From Thai Acute Myeloid Leukemia Registry.
Chanswangphuwana C, Polprasert C, Owattanapanich W, Kungwankiattichai S, Rattarittamrong E, Rattanathammethee T, Limvorapitak W, Saengboon S, Niparuck P, Puavilai T, Julamanee J, Saelue P, Wanitpongpun C, Nakhakes C, Prayongratana K, Sriswasdi C. Chanswangphuwana C, et al. Among authors: puavilai t. Clin Lymphoma Myeloma Leuk. 2022 Oct;22(10):e915-e921. doi: 10.1016/j.clml.2022.06.005. Epub 2022 Jun 12. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35792033
Treatment Outcomes and Clinical Relevance in Patients with Double Expressor DLBCL.
Rungwittayatiwat S, Boonsakan P, Chantrathammachart P, Puavilai T, Pukiat S, Phusanti S, Boonyawat K, Wacharapornin P, Angchaisuksiri P, Ungkanont A, Chuncharunee S, Niparuck P. Rungwittayatiwat S, et al. Among authors: puavilai t. Mediterr J Hematol Infect Dis. 2021 Nov 1;13(1):e2021063. doi: 10.4084/MJHID.2021.063. eCollection 2021. Mediterr J Hematol Infect Dis. 2021. PMID: 34804437 Free PMC article.
23 results